DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Epirubicin (Epirubicin) - Febrile Neutropenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Febrile Neutropenia (16)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epirubicin where reactions include febrile neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Epirubicin side effects in female

Reported by a physician from Netherlands on 2012-07-30

Patient: female, weighing 61.5 kg (135.3 pounds)

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 885 mg, unk
    Indication: Breast Cancer
    Start date: 2011-03-22

Epirubicin
    Dosage: 177 mg, unk
    Indication: Breast Cancer
    Start date: 2011-03-22

Fluorouracil
    Dosage: 885 mg, unk
    Indication: Breast Cancer
    Start date: 2011-03-22

NO Treatment Received
    Dosage: no treatment received
    Indication: Breast Cancer

Other drugs received by patient: Granisetron



Possible Epirubicin side effects in female

Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-07-23

Patient: female

Reactions: Diarrhoea, Chills, Febrile Neutropenia, Headache

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: every cycle
    Indication: Breast Cancer
    Start date: 2010-12-08
    End date: 2011-01-05

Epirubicin
    Dosage: every cycle
    Indication: Breast Cancer
    Start date: 2010-12-08
    End date: 2011-01-05

Fluorouracil
    Dosage: every cycle
    Indication: Breast Cancer
    Start date: 2010-12-08
    End date: 2011-01-05

Other drugs received by patient: Dexamethasone; Onsia



Possible Epirubicin side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-07-23

Patient: 48 year old female

Reactions: Vomiting, Nausea, Febrile Neutropenia, Oropharyngeal Pain

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 830mg, every cycle; 800mg, every cycle
    Indication: non-Small Cell Lung Cancer
    Start date: 2010-10-27

Cyclophosphamide
    Dosage: 830mg, every cycle; 800mg, every cycle
    Indication: non-Small Cell Lung Cancer
    Start date: 2010-10-06
    End date: 2010-10-06

Epirubicin
    Dosage: 166mg every cycle; 140mg, every cycle
    Indication: non-Small Cell Lung Cancer
    Start date: 2010-10-06
    End date: 2010-10-06

Epirubicin
    Dosage: 166mg every cycle; 140mg, every cycle
    Indication: non-Small Cell Lung Cancer
    Start date: 2010-10-27

Fluorouracil
    Dosage: 830 mg every cycle; 700 mg, every cycle
    Indication: Breast Cancer
    Start date: 2010-10-06

Fluorouracil
    Dosage: 830 mg every cycle; 700 mg, every cycle
    Indication: Breast Cancer
    Start date: 2010-10-27



Possible Epirubicin side effects in female

Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-07-23

Patient: female, weighing 61.2 kg (134.6 pounds)

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: see image
    Indication: Breast Cancer
    Start date: 2009-12-02
    End date: 2009-12-02

Cyclophosphamide
    Dosage: see image
    Indication: Breast Cancer
    Start date: 2009-12-30

Epirubicin
    Dosage: see image
    Indication: Breast Cancer
    Start date: 2009-12-30

Epirubicin
    Dosage: see image
    Indication: Breast Cancer
    Start date: 2009-12-02
    End date: 2009-12-02

Fluorouracil
    Dosage: see image
    Indication: Breast Cancer
    Start date: 2009-12-02
    End date: 2009-12-02

Fluorouracil
    Dosage: see image
    Indication: Breast Cancer
    Start date: 2009-12-30



Possible Epirubicin side effects in female

Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-07-23

Patient: female

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
    Indication: Breast Cancer
    Start date: 2011-01-05
    End date: 2011-01-05

Cyclophosphamide
    Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
    Indication: Breast Cancer
    Start date: 2011-02-16
    End date: 2011-02-16

Cyclophosphamide
    Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
    Indication: Breast Cancer
    Start date: 2010-12-08
    End date: 2010-12-08

Epirubicin
    Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
    Indication: Breast Cancer
    Start date: 2011-02-16
    End date: 2011-02-16

Epirubicin
    Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
    Indication: Breast Cancer
    Start date: 2010-12-08
    End date: 2010-12-08

Epirubicin
    Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
    Indication: Breast Cancer
    Start date: 2011-01-05
    End date: 2011-01-05

Fluorouracil
    Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
    Indication: Breast Cancer
    Start date: 2011-01-05
    End date: 2011-01-05

Fluorouracil
    Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
    Indication: Breast Cancer
    Start date: 2011-02-16
    End date: 2011-02-16

Fluorouracil
    Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
    Indication: Breast Cancer
    Start date: 2010-12-08
    End date: 2010-12-08

Other drugs received by patient: Dexamethasone; Ondansetron



Possible Epirubicin side effects in 62 year old female

Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-07-20

Patient: 62 year old female

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: (df), (df; dose reduced)
    Indication: Breast Cancer
    Start date: 2010-07-23
    End date: 2010-07-23

Epirubicin
    Dosage: (df), (df; dose reduced)
    Indication: Breast Cancer
    Start date: 2010-07-23
    End date: 2010-07-23

Fluorouracil
    Dosage: (df), (df; dose reduced)
    Indication: Breast Cancer
    Start date: 2010-07-23
    End date: 2010-07-23



Possible Epirubicin side effects in female

Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-07-20

Patient: female

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: (800 mg; every cycle), (800 mg; every cycle)
    Indication: Breast Cancer
    Start date: 2009-10-29
    End date: 2009-10-29

Cyclophosphamide
    Dosage: (800 mg; every cycle), (800 mg; every cycle)
    Indication: Breast Cancer
    Start date: 2010-01-04
    End date: 2010-01-04

Epirubicin
    Dosage: (150 mg; every cycle), (150 mg; every cycle)
    Indication: Breast Cancer
    Start date: 2010-01-04
    End date: 2010-01-04

Epirubicin
    Dosage: (150 mg; every cycle), (150 mg; every cycle)
    Indication: Breast Cancer
    Start date: 2009-10-29
    End date: 2009-10-29

Fluorouracil
    Dosage: (800 mg; every cycle), (800 mg; every cycle)
    Indication: Breast Cancer
    Start date: 2010-01-04
    End date: 2010-01-04

Fluorouracil
    Dosage: (800 mg; every cycle), (800 mg; every cycle)
    Indication: Breast Cancer
    Start date: 2009-10-29
    End date: 2009-10-29

Other drugs received by patient: Ondansetron; Lenograstim; Dexamethasone



Possible Epirubicin side effects in 63 year old female

Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-07-20

Patient: 63 year old female

Reactions: Febrile Neutropenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: (df; every cycle), (df; dose reduced)
    Indication: Breast Cancer
    Start date: 2010-06-30
    End date: 2010-06-30

Epirubicin
    Dosage: (df; every cycle), (df; dose reduced)
    Indication: Breast Cancer
    Start date: 2010-06-30
    End date: 2010-06-30

Fluorouracil
    Dosage: (df; every cycle), (df; dose reduced)
    Indication: Breast Cancer
    Start date: 2010-06-30
    End date: 2010-06-30



Possible Epirubicin side effects in

Reported by a health professional (non-physician/pharmacist) from Egypt on 2012-06-15

Patient:

Reactions: Febrile Neutropenia

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 500 mg/m2 every three weeks intravenous not otherwise specified
    Indication: Inflammatory Carcinoma of Breast Stage III

Epirubicin
    Dosage: 100 mg/m2 every three weeks intravenous not other wise
    Indication: Inflammatory Carcinoma of Breast Stage III

Fluorouracil
    Dosage: 500 mg/m2 every three week (intravenously bolus)
    Indication: Inflammatory Carcinoma of Breast Stage III



Possible Epirubicin side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-24

Patient: female

Reactions: Febrile Neutropenia

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer

Epirubicin
    Indication: Breast Cancer

Fluorouracil
    Indication: Breast Cancer

Paclitaxel
    Indication: Breast Cancer

Trastuzumab
    Indication: Breast Cancer

Trastuzumab



Possible Epirubicin side effects in female

Reported by a physician from Switzerland on 2012-03-02

Patient: female, weighing 41.0 kg (90.2 pounds)

Reactions: Febrile Neutropenia, Pyrexia, Cough

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epirubicin
    Dosage: 75mgm2 cyclic
    Indication: Neoplasm
    Start date: 2010-04-27

Votrient
    Dosage: 400mg per day
    Administration route: Oral
    Indication: Neoplasm
    Start date: 2010-04-28

Other drugs received by patient: Dexamethasone; Dexamethasone



Possible Epirubicin side effects in 47 year old female

Reported by a physician from France on 2012-03-02

Patient: 47 year old female

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 940 mg, unk
    Start date: 2010-07-22

Epirubicin
    Dosage: 190 mg, unk
    Start date: 2010-07-22

Fluorouracil
    Dosage: 940 mg, unk
    Start date: 2010-07-22

Panitumumab
    Dosage: 690 mg, unk
    Indication: Breast Cancer
    Start date: 2010-07-22

Other drugs received by patient: Monazole; Solu-Medrol; Emend; Doxycycline; Medrol; Zofran



Possible Epirubicin side effects in 47 year old female

Reported by a physician from France on 2012-02-29

Patient: 47 year old female

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 940 mg, unk
    Start date: 2010-07-22

Epirubicin
    Dosage: 190 mg, unk
    Start date: 2010-07-22

Fluorouracil
    Dosage: 940 mg, unk
    Start date: 2010-07-22

Panitumumab
    Dosage: 690 mg, unk
    Indication: Breast Cancer
    Start date: 2010-07-22

Other drugs received by patient: Zofran; Emend; Solu-Medrol; Monazole; Doxycycline; Medrol



Possible Epirubicin side effects in 47 year old female

Reported by a physician from France on 2012-02-28

Patient: 47 year old female

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 940 mg, unk
    Start date: 2010-07-22

Epirubicin
    Dosage: 190 mg, unk
    Start date: 2010-07-22

Fluorouracil
    Dosage: 940 mg, unk
    Start date: 2010-07-22

Panitumumab
    Dosage: 690 mg, unk
    Indication: Breast Cancer
    Start date: 2010-07-22

Other drugs received by patient: Emend; Doxycycline; Solu-Medrol; Monazole; Medrol; Zofran



Possible Epirubicin side effects in female

Reported by a physician from Italy on 2011-11-04

Patient: female, weighing 58.0 kg (127.6 pounds)

Reactions: Febrile Neutropenia, Pneumonitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 656 mg, unk
    Indication: Breast Cancer
    Start date: 2011-06-28

Epirubicin
    Dosage: 131.20 mg, unk
    Indication: Breast Cancer
    Start date: 2011-06-28

Fluorouracil
    Dosage: 656 mg, unk
    Indication: Breast Cancer
    Start date: 2011-06-28

NO Treatment Received
    Dosage: no treatment
    Indication: Breast Cancer

Other drugs received by patient: Augmentin '125'



Possible Epirubicin side effects in female

Reported by a physician from Italy on 2011-10-12

Patient: female, weighing 58.0 kg (127.6 pounds)

Reactions: Febrile Neutropenia, Pneumonitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 656 mg, unk
    Indication: Breast Cancer
    Start date: 2011-06-28

Epirubicin
    Dosage: 131.20 mg, unk
    Indication: Breast Cancer
    Start date: 2011-06-28

Fluorouracil
    Dosage: 656 mg, unk
    Indication: Breast Cancer
    Start date: 2011-06-28

NO Treatment Received
    Dosage: no treatment
    Indication: Breast Cancer

Other drugs received by patient: Augmentin '125'

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012